Bio-inspired drug delivery systems: an emerging platform for targeted cancer therapy

Gella Maelys Ngandeu Neubi1, Yaw Opoku-Damoah2, Xiaochen Gu3

  • 1State Key Laboratory of Natural Medicines, Department of Pharmaceutics, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210009, China. zhoujianop60@163.com dydszyzf@163.com.

Biomaterials Science
|March 23, 2018
PubMed

Insights

Bio-inspired drug delivery platforms offer innovative solutions for cancer therapy. These systems mimic natural bodily components for targeted delivery, improving treatment efficacy and reducing side effects.

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Oncology

Background:

  • Effective cancer treatment requires targeted drug delivery to maximize efficacy and minimize systemic toxicity.
  • Traditional chemotherapy faces challenges with non-specific distribution and severe side effects.
  • Bio-inspired materials offer a promising avenue for developing advanced drug delivery systems.

Purpose of the Study:

  • To provide a comprehensive review of intelligent bio-inspired drug delivery platforms for cancer therapy.
  • To evaluate the advantages and limitations of these innovative systems.
  • To discuss their future clinical potential in cancer treatment and diagnosis.

Main Methods:

  • Literature review of recent studies on bio-inspired drug delivery platforms.
  • Analysis of natural particulates and biomaterials used in drug delivery.
  • Evaluation of system performance, biodistribution, and clinical applicability.

Main Results:

  • Bio-inspired platforms demonstrate superior systemic biodistribution compared to non-native systems.
  • These platforms offer versatility for both cancer therapy and diagnosis.
  • Various natural materials and biomimetic approaches show significant promise.

Conclusions:

  • Intelligent bio-inspired delivery platforms represent a significant advancement in cancer drug delivery.
  • Further research and development are crucial for their successful clinical translation.
  • These systems hold great potential for revolutionizing cancer treatment strategies.

Related Concept Videos

Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
1
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
1
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Transdermal Drug Delivery Systems01:18

Transdermal Drug Delivery Systems

Transdermal drug delivery systems (TDDS) enable the controlled release of drugs across the skin into systemic circulation. They are particularly advantageous for drugs with short half-lives or narrow therapeutic indices, as they maintain consistent plasma concentrations and reduce the risk of subtherapeutic or toxic levels.TDDS are categorized into monolithic, reservoir, and mixed systems. Monolithic systems embed the drug in a polymer matrix, where diffusion governs release. Reservoir systems...
3
Ophthalmic Drug Delivery Systems01:23

Ophthalmic Drug Delivery Systems

Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
1
Drug Delivery Systems: Different Types01:27

Drug Delivery Systems: Different Types

Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
1